Regulatory Frameworks and Clinical Development of Orthobiologics Across Asia and Europe.
Where this comes from
- Record sourced from PubMed, PMID 42430777.
- Also identified by DOI 10.2106/JBJS.26.00667.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Asia and Europe are rapidly expanding hubs for orthobiologics, driven by aging populations, advancing infrastructure, and growing evidence for regenerative therapies. Regulatory heterogeneity across both regions remains a major barrier, highlighting the need for international collaboration to support safe, responsible innovation.